S
Superbranche
Biotech & Life Sciences · Strasbourg, France · Founded 2019
Biotech nanoparticles transforming cancer diagnosis and treatment MoreLess
SuperBranche is an innovative biotech startup that specializes in developing advanced nanoparticles for the diagnosis and treatment of cancer tumors. Founded by Emmanuel Bertomeu, the company has spent over a decade in interdisciplinary research and development (R&D) to create cutting-edge solutions that significantly improve cancer care. SuperBranche's technology not only aids in the initial diagnosis of cancer but also enhances the ongoing monitoring and treatment of cancer cells, making it a comprehensive tool in the fight against this disease.
The company primarily serves healthcare providers, including hospitals, clinics, and research institutions, that are focused on oncology. By offering a more precise and efficient method for diagnosing and treating cancer, SuperBranche aims to improve patient outcomes and reduce the overall cost of cancer care.
SuperBranche operates in the biotech and healthcare market, which is a rapidly growing sector driven by advancements in medical technology and an increasing global focus on improving healthcare outcomes. The company's business model revolves around the development and commercialization of its proprietary nanoparticle technology. It generates revenue through the sale of its diagnostic and therapeutic products to healthcare providers and through partnerships with other biotech firms and research institutions.
Additionally, SuperBranche has garnered significant recognition in the industry, including winning the prestigious Grand Prix du Jury at the 2019 i-Lab Competition. This accolade underscores the company's innovative approach and the potential impact of its technology on cancer treatment.
In summary, SuperBranche is a pioneering biotech firm dedicated to revolutionizing cancer diagnosis and treatment through its advanced nanoparticle technology. It serves healthcare providers in the oncology sector and operates on a business model focused on product sales and strategic partnerships.
Keywords: biotech, nanoparticles, cancer diagnosis, cancer treatment, oncology, healthcare, R&D, innovation, Emmanuel Bertomeu, i-Lab Competition.
Company overview
Superbranche company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Strasbourg, France
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 88.9
Valuation & funding
Superbranche funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Feb 2025 | $14M | $57M | Capital Grand Est · Bpifrance | ↗ |
| SEED✓Equity / VC | Nov 2020 | $440K | $1.8M | Alsace Business Angels · Bpifrance · Finck Ventures | ↗ |
| SPINOUT✓Other financing | Mar 2019 | $0 | — | French National Centre for Scientific Research - CNRS · University of Strasbourg · CNRS Innovation | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 20 |
| 2025 | 15 |
| 2024 | 10 |
| 2023 | 10 |
Growth signals
Superbranche website traffic
Latest recorded traffic for Superbranche is 280 monthly website visits, down 6.7% over the last three months. Superbranche's team grew 33.3% over the past year.
Comparisons
Superbranche compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Superbranche's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Superbranche has talent and traffic
team presence
In the news
Latest news about Superbranche
Recent press, funding announcements, and product moves mentioning Superbranche — open to read from the original sources.
Market sentiment
What the market is saying about Superbranche
An AI-synthesized read of the highest-engagement posts about Superbranche on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Superbranche’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.